Biotech · Private company
Zymeworks BC Inc.
Track this companyFree. Adds Zymeworks BC Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ZW171Phase 1 · Mesothelin-expressing Advanced CancersClinicalTrials.gov · fetched Nov 12, 2026
- ZW191Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ZW251Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- ZW49Phase 1 · HER2-expressing CancersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study of ZW251 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Oct 21, 2025ClinicalTrials.gov NCT07164313 · fetched Nov 12, 2026
- A Study of ZW191 in Participants With Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 30, 2024ClinicalTrials.gov NCT06555744 · fetched Nov 12, 2026
- A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing CancersPHASE1 · TERMINATED · started Sep 30, 2024ClinicalTrials.gov NCT06523803 · fetched Nov 12, 2026
- A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)PHASE2 · RECRUITING · started Nov 16, 2021ClinicalTrials.gov NCT05035836 · fetched Nov 12, 2026
- ZW25 in Women With Endometrial CancersPHASE2 · COMPLETED · started Aug 12, 2020ClinicalTrials.gov NCT04513665 · fetched Nov 12, 2026
- A Dose Finding Study of ZW49 in Patients With HER2-Positive CancersPHASE1 · COMPLETED · started Apr 15, 2019ClinicalTrials.gov NCT03821233 · fetched Nov 12, 2026